The Power of Phase I Studies to Detect Clinical Relevant QTc Prolongation: A Resampling Simulation Study

Figure 2

Power of CE modeling as a function of the number of subjects on placebo. In all simulations, 9 subjects were used in the active group, while the number on placebo was varied as given on the -axis. Shaded range is considered acceptable.